Matrix metalloproteinases and diabetic vascular complications

Area of Science:

• Cardiovascular Research
• Endocrinology
• Biochemistry

Background:

• Diabetes mellitus (DM) significantly increases cardiovascular events and microvascular complications.
• Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) are increasingly recognized for their role in atherosclerosis.
• The specific involvement of MMPs/TIMPs in diabetic angiopathy requires further clarification.

Purpose of the Study:

• To explore the relationship between matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the context of diabetic vascular complications.
• To investigate the impact of hyperglycemia on MMP expression and activity in diabetes.
• To assess the potential role of MMPs/TIMPs imbalance in diabetic atherosclerosis, plaque rupture, and thrombotic events.

Main Methods:

• Review of existing evidence on MMPs/TIMPs in atherosclerosis and diabetes.
• Analysis of the effects of hyperglycemia on MMP expression and activity.
• Examination of the proposed mechanisms linking MMPs/TIMPs to diabetic vascular pathology.

Main Results:

• Hyperglycemia can elevate MMP expression and activity, leading to vascular alterations.
• Reduced MMP proteolytic activity is associated with diabetic nephropathy.
• An imbalance between MMPs and TIMPs in atherosclerotic plaques may promote matrix degradation and plaque rupture.
• MMPs may influence blood coagulability, potentially contributing to acute thrombotic events in diabetes.

Conclusions:

• MMPs and TIMPs play a complex role in diabetic vascular disease, influencing atherosclerosis and thrombosis.
• Further research is needed to establish a causal link between MMPs/TIMPs and diabetic atherosclerosis.
• The efficacy of MMP inhibitors in preventing cardiovascular events in diabetic patients requires further investigation.